Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Taro Pharmaceutical Industries Ltd. (TARO)

47.53   -1.04 (-2.14%) 01-19 07:55
Open: 48.5 Pre. Close: 48.57
High: 48.58 Low: 46.775
Volume: 20,878 Market Cap: 1,786M
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 48.638 - 48.942 48.942 - 49.157
Low: 46.068 - 46.442 46.442 - 46.707
Close: 47.034 - 47.587 47.587 - 47.977

Technical analysis

as of: 2022-01-18 4:34:41 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 57.13     One year: 59.95
Support: Support1: 45.00    Support2: 37.44
Resistance: Resistance1: 48.91    Resistance2: 51.33
Pivot: 48.84
Moving Average: MA(5): 49.10     MA(20): 48.89
MA(100): 57.70     MA(250): 67.14
MACD: MACD(12,26): -0.77     Signal(9): -0.95
Stochastic oscillator: %K(14,3): 59.26     %D(3): 69.04
RSI: RSI(14): 42.61
52-week: High: 80.00  Low: 45.00  Change(%): -38.4
Average Vol(K): 3-Month: 1731  10-Days: 1795

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TARO has closed above bottom band by 22.8%. Bollinger Bands are 19.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 18 Jan 2022
Chemotherapy-Induced Acral Erythema Treatment Market 2022 Escalate Strategic Planning, Competitive Landscape and Forecast to 2031 - Taiwan News

Tue, 18 Jan 2022
Taro Pharmaceutical Industries (NYSE:TARO) PT Lowered to $75.00 at HC Wainwright - MarketBeat

Thu, 13 Jan 2022
Sun Pharma gains 4% on earnings optimism, stock scales a 5-year high - Business Standard

Wed, 12 Jan 2022
Buy Sun Pharmaceutical Industries, target price Rs 965: ICICI Direct - Economic Times

Mon, 03 Jan 2022
Hot Stocks: AAPL touches $3T; retailers rally; GILT soars; TARO sets low; APLT drops on delayed application - Seeking Alpha

Thu, 04 Nov 2021
TARO PHARMACEUTICALS U.S.A., INC. ENTERS INTO SETTLEMENT AGREEMENT IN In re Generic Pharmaceuticals Pricing Antitrust Litigation - Form 6-K - Marketscreener.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 38
Shares Float (M) 8
% Held by Insiders 78.48
% Held by Institutions 12.98
Shares Short (K) 101
Shares Short P. Month (K) 97

Stock Financials

EPS 0.200
EPS Est This Year 9.490
EPS Est Next Year 7.990
Book Value (p.s.) 44.500
Profit Margin 1.35
Operating Margin 24.85
Return on Assets (ttm) 3.8
Return on Equity (ttm) 0.5
Qtrly Rev. Growth -7.6
Gross Profit (p.s.) 7.894
Sales Per Share 15.104
EBITDA (p.s.) 4.422
Qtrly Earnings Growth -48.30
Operating Cash Flow (M) 86
Levered Free Cash Flow (M) 129

Stock Valuations

PE Ratio 237.65
PEG Ratio
Price to Book value 1.07
Price to Sales 3.15
Price to Cash Flow 20.80

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2018-12-27
Ex-Dividend Date 2018-12-09
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.